NuuVim
Ranked #226 · Grade C
A rare needle-free option at true price parity — $79/mo semaglutide or $133/mo tirzepatide, injectable or oral, same price — though NuuVim frames it as a new-patient rate with an unpublished refill tier, and its 50-state coverage claim couldn't be confirmed on its own live site this pass.
- $20/mo cheaper than CoreAge Rx
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
NuvaHealth
Ranked #252 · Grade C
A LegitScript-certified compounded GLP-1 platform advertising $89/mo semaglutide and $139/mo tirzepatide — but those are first-month-only promos, the real month-two price is never published, and nothing addresses PCOS, postpartum, or breastfeeding.
- $10/mo cheaper than CoreAge Rx
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
Strut Health
Ranked #9 · Grade B−
Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.
- has an oral option if you would rather not inject
ShedRx
Ranked #13 · Grade C
The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
SynergyRX
Ranked #14 · Grade C
Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
Shapely
Ranked #94 · Grade C
Shapely is the first provider in this batch that takes insurance — it says it is in network with Medicare and major PPO plans, and quotes brand-name co-pays of "typically $25 per month". That genuinely changes the arithmetic for anyone with coverage. What has to be read carefully is what the membership buys: $99 a month, $49 for the first, and it explicitly does not include medications or labs. So the compounded prices, $99 for semaglutide and $166 for tirzepatide, sit on top of the membership rather than replacing it.
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject
yourEra
Ranked #15 · Grade C
A low-entry, all-in compounded program with both molecules and a clean cancel-anytime policy — appealing if the starting price holds, but the ongoing rate isn't published and the outcome claims are unverified marketing.
SnagRx
Ranked #42 · Grade C
Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.
- $30/mo cheaper than CoreAge Rx
BeyondMD
Ranked #69 · Grade C
BeyondMD publishes its prices before intake and names eleven clinicians with real bios, both of which are uncommon — but 'Starting at $125' is the floor of a $139-to-$449 band that appears on exactly one page, plus a $34 consultation fee and unpriced shipping, and the number you would actually pay is quoted on a phone call because every GLP-1 button leads to a lead form rather than a cart. Its Terms of Service contain no refund policy, no cancellation policy and no auto-renewal terms at all — the word 'refund' does not appear once in 44 KB.
- offers FDA-approved brand pens, not just compounded
- has an oral option if you would rather not inject